Resultados: 12

    Guideline No 428: management of dichorionic twin pregnancies

    J. obstet. gynaecol. Can; 44 (7), 2022
    To review evidence-based recommendations for the management of dichorionic twin pregnancies. Pregnant women with a dichorionic twin pregnancy. Implementation of the recommendations in this guideline may improve the management of twin pregnancies and reduce neonatal and maternal morbidity and mortality. P...

    Guideline No 427: folic acid and multivitamin supplementation for prevention of folic acid–sensitive congenital anomalies

    J. obstet. gynaecol. Can; 44 (6), 2022
    To provide updated guidance on pre-conception folic acid and multivitamin supplementation for primary and secondary (recurrence) prevention of neural tube defects and other folate-sensitive congenital anomalies. Women aged 12-45 years who could become pregnant should be aware of the risk of serious birth...

    Guideline No. 426: Hypertensive disorders of pregnancy: diagnosis, prediction, prevention, and management

    J. obstet. gynaecol. Can; 44 (5), 2022
    This guideline was developed by maternity care providers from obstetrics and internal medicine. It reviews the diagnosis, evaluation, and management of the hypertensive disorders of pregnancy (HDPs), the prediction and prevention of preeclampsia, and the postpartum care of women with a previous HDP. Impl...

    Guideline No. 403: initial investigation and management of adnexal masses

    J. obstet. gynaecol. Can; 42 (8), 2020
    To aid primary care physicians, emergency medicine physicians, and gynaecologists in the initial investigation of adnexal masses, defined as lumps that appear near the uterus or in or around ovaries, fallopian tubes, or surrounding connective tissue, and to outline recommendations for identifying women w...

    Guideline No. 404: initial investigation and management of benign ovarian masses

    J. obstet. gynaecol. Can; 42 (8), 2020
    To provide recommendations for a systematic approach to the initial investigation and management of a benign ovarian mass and facilitate patient referral to a gynaecologic oncologist for management....

    Oral Health: supporting adults who require assistance second edition

    BPGs promote consistency and excellence in clinical care, administrative policies, procedures and education, with the aim of achieving optimal health outcomes for people, communities and the health system as a whole. This BPG replaces the RNAO BPG Oral Health: Nursing Assessment and Intervention, which w...

    No. 397: conservative care of urinary incontinence in women

    J. obstet. gynaecol. Can; 42 (4), 2020
    To outline the evidence for conservative care, including both assessment and management options, for urinary incontinence in women.Relevant primary care providers and medical specialists including but not limited to physicians, nurses, midwives, and pelvic health physiotherapists. Women (>18 years of age...

    Deprescribing antihyperglycemic agents in older persons: evidence-based clinical practice guideline

    Can. fam. physician; 63 (11), 2017
    OBJECTIVE: To develop an evidence-based guideline to help clinicians make decisions about when and how to safely taper, stop, or switch antihyperglycemic agents in older adults. METHODS: We focused on the highest level of evidence available and sought input from primary care professionals in guideline de...

    Deprescribing proton pump inhibitors: evidence-based clinical practice guideline

    Can. fam. physician; 63 (5), 2017
    OBJECTIVE: To develop an evidence-based guideline to help clinicians make decisions about when and how to safely taper or stop proton pump inhibitors (PPIs); to focus on the highest level of evidence available and seek input from primary care professionals in the guideline development, review, and endors...